OHE is very pleased to announce that associate professor Lotte Steuten will be joining OHE in February as Vice-President and Head of Consulting.
Lotte is currently an associate member at the Hutchinson Institute for Cancer Outcomes Research (HICOR) at the Fred Hutchinson Cancer Research Center, and an affiliate associate professor in the Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute at the University of Washington, Seattle. She is also co-founder and Chief Scientific Officer of Panaxea bv, a health innovation consultancy firm with offices in the Netherlands, Belgium and Germany.
Previously, Lotte has worked as (senior) investigator at well-known health economic departments of universities in the UK and the Netherlands where she conducted numerous studies varying from the early assessment of specialized medical technologies to full economic evaluation of chronic care programs. In various roles she was responsible for developing, leading and conducting health economic research programs and was director of a health sciences graduate education program. Lotte serves on the ISPOR Value of Information TaskForce and on the editorial board of various academic journals. She has an MSc and PhD (cum laude) from Maastricht University,
Her research interests include developing and applying health economic and decision-analytic research methods to accelerate patient access to high value new screening, diagnostic and treatment options. Her research expertise is in the fields of health economics and health services research. She specializes in developing and applying quantitative methods for estimating and comparing the expected health and economic benefits of new approaches and interventions in disease prevention and treatment, and prioritizing data collection to efficiently build the evidence for promising new interventions.
Announcing the appointment, OHE Chief Executive Professor Graham Cookson said “Lotte has a rare combination of strong academic credentials combined with experience leading major consulting programmes. Her international profile, energy and complementary research interests make her the perfect person to lead OHE’s growing consulting practice.”
On her appointment, Lotte Steuten said, “The diversity of research expertise and analytic skills of OHE's well-respected and exceptionally talented team provides for a unique opportunity to tackle the economic and policy challenges that affect the delivery of health care and the future of pharmaceutical and life sciences industries. I am thrilled to join OHE’s inspiring work environment to lead its independent and high-quality research-based consultancy.”
Further information on Lotte is available on the OHE website.
Posted in | Tagged